ID Source | ID |
---|---|
PubMed CID | 3081380 |
SCHEMBL ID | 39903 |
MeSH ID | M0102318 |
Synonym |
---|
3'-cytidylic acid, 5'-(dihydrogen phosphate) |
cytidine 3',5'-diphosphate |
3',5'-cdp |
2922-94-3 |
5'-phosphocytidine 3'-phosphate |
[(2r,3s,4r,5r)-5-(4-amino-2-oxopyrimidin-1-yl)-4-hydroxy-2-(phosphonooxymethyl)oxolan-3-yl] dihydrogen phosphate |
SCHEMBL39903 |
DTXSID80183481 |
cytidine 3',5'-bis(phosphate) |
cytidine 3',5'-bis(dihydrogen phosphate) |
Q27465101 |
(2r,3s,4r,5r)-5-(4-amino-2-oxopyrimidin-1(2h)-yl)-4-hydroxy-2-((phosphonooxy)methyl)tetrahydrofuran-3-yl dihydrogen phosphate |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 4 (44.44) | 18.7374 |
1990's | 3 (33.33) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.02) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (11.11%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (88.89%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |